Selank vs Semax: Anxiety Relief vs Cognitive Enhancement — Russian Peptides Compared

Selank and Semax are both synthetic peptide nootropics developed at the Institute of Molecular Genetics in Moscow, both used extensively in Russian clinical psychiatry and neurology, and both available internationally as research peptides. Yet despite their shared origin, they serve very different purposes. Selank is primarily an anxiolytic — it calms, stabilizes mood, and modulates the immune system. Semax is primarily a cognitive enhancer — it sharpens focus, boosts BDNF, and produces a stimulant-like alertness without the jitter. Understanding which does what is essential before adding either to your stack.

What Is Selank?

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) created by attaching the tuftsin fragment Thr-Lys-Pro-Arg to the proline-glycine-proline sequence for metabolic stability. Tuftsin is a natural immunomodulatory tetrapeptide derived from the IgG antibody.

Primary mechanisms:

• Modulates GABA-A receptor activity in a benzodiazepine-like manner — reduces anxiety without sedation or dependence
• Stabilizes enkephalin breakdown, prolonging endogenous opioid signaling
• Modulates serotonin and dopamine metabolism in the prefrontal cortex
• Demonstrated immunomodulatory effects: normalizes IL-6, IL-1β, and TNF-α toward balanced immune function

Selank has been studied in Russian clinical trials for generalized anxiety disorder, phobias, asthenic conditions (fatigue and cognitive decline under stress), and as an immune adjuvant. It is registered as a pharmaceutical in Russia and several Eastern European countries.

Full details in the Selank peptide guide.

What Is Semax?

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the ACTH(4-7) sequence with a proline-glycine-proline stabilizing extension. It is one of Russia's most used nootropic pharmaceutical agents, widely prescribed for stroke recovery, ADHD-like cognitive deficits, and enhancement of learning and memory.

Primary mechanisms:

• Increases BDNF (brain-derived neurotrophic factor) expression dramatically — the most significant pro-cognitive mechanism
• Increases NGF (nerve growth factor), promoting neuronal survival and plasticity
• Activates dopaminergic and serotonergic systems in the prefrontal cortex
• Modulates the HPA axis (hypothalamic-pituitary-adrenal) without sustained cortisol elevation

Semax has an extraordinary pharmacological profile relative to its size. Its BDNF-elevating effect rivals that of exercise in some animal studies, and BDNF is the single most important neurotrophic factor for learning, memory consolidation, and depression resistance.

See the Semax peptide guide for dosing and protocol details.

Mechanism Comparison

| Feature | Selank | Semax | |---|---|---| | Primary effect | Anxiolytic, immunomodulatory | Cognitive enhancement, neuroprotective | | Key neurotransmitter effects | GABA modulation, enkephalin stabilization | BDNF/NGF upregulation, dopamine/serotonin | | Stimulating vs calming | Calming, anti-anxiety | Mildly stimulating, alertness-enhancing | | HPA axis effect | Normalizes stress response | Modulates HPA, reduces stress reactivity | | Clinical use (Russia) | Anxiety, asthenia, immunodeficiency | Stroke, ADHD, cognitive enhancement | | Dependence risk | Very low — no tolerance reported | Very low — non-addictive | | Half-life | ~2 minutes (intranasal absorption extends effective window) | ~2 minutes (same intranasal delivery consideration) | | Administration | Intranasal drops or spray (primary), subcutaneous | Intranasal drops or spray (primary), subcutaneous |

The BDNF Distinction

The most important mechanistic difference is Semax's BDNF upregulation. BDNF is often called "Miracle-Gro for the brain" — it promotes neurogenesis, strengthens synaptic connections, protects neurons from damage, and is strongly inversely correlated with depression, anxiety, and cognitive decline.

Selank does not produce meaningful BDNF elevation. It works primarily through GABA modulation and enkephalin stabilization — completely different signal pathways that produce calming and anxiolytic effects rather than neuroplasticity enhancement.

This means that if your primary goal is cognitive performance, memory, learning, or neuroplasticity, Semax is the more targeted tool. If your goal is anxiety reduction, stress resilience, or immune stabilization, Selank is the better fit.

Clinical Profile: What Each Feels Like

Based on extensive user reports and the Russian clinical literature:

Selank users typically report:

• Reduced baseline anxiety within 15–30 minutes of intranasal dosing
• Improved emotional stability without sedation or cognitive dulling
• Enhanced focus under stress (reduced anxiety-induced mental fog)
• Mild mood elevation — "contentment" rather than euphoria
• Immune normalization in individuals with chronic immune dysregulation

Semax users typically report:

• Enhanced focus and working memory within 20–40 minutes
• Increased verbal fluency and processing speed
• Moderate energy increase without the edge of stimulants
• Improved ability to enter and sustain deep work states
• Some report mild anxiety increase at higher doses — a key difference

The anxiety increase with Semax at higher doses is worth flagging. Semax activates dopaminergic pathways in a stimulant-adjacent manner, which can increase arousal to the point of restlessness in sensitive individuals. Selank does the opposite. This creates a natural synergy.

Stacking Selank and Semax

The Selank + Semax stack is one of the most popular combinations in the Russian nootropic community and for good reason: Semax provides the cognitive uplift and BDNF boost, while Selank manages the anxiety edge and provides immunomodulatory support. Together they produce a state of calm alertness that neither achieves as well alone.

Stack protocol:

• Semax: 300–600 mcg intranasal (2–3 drops of 1% solution per nostril) in the morning
• Selank: 250–500 mcg intranasal 1–2x daily, or specifically when anxiety or stress peaks
• Both can be dosed simultaneously or at different times depending on preference

Some users take Semax in the morning for productivity and Selank in the afternoon or evening for stress recovery and sleep quality. This covers both the activation and restoration arcs of the day.

N-Acetyl Semax and N-Acetyl Selank

Modified versions — N-Acetyl Semax and N-Acetyl Selank — add an acetyl group to the N-terminus, which increases lipophilicity and potentially enhances CNS penetration and duration of action. The acetylated forms are generally considered more potent per microgram and may produce more pronounced effects at lower doses.

If using the acetylated versions, doses are typically reduced by 30–50% relative to the standard forms.

Research Background and Regulatory Status

Both peptides were developed at the Institute of Molecular Genetics (Moscow) and have been studied in Russian clinical settings since the 1980s and 1990s. They are registered pharmaceutical drugs in Russia (Selank: anxiolytic; Semax: nootropic/neuroprotective). Western clinical trials are largely absent, and they are sold as research chemicals in the US and EU.

This Russian research base is a double-edged sword: it is genuine clinical data from real patient populations, but it is not Western peer-reviewed RCT data and carries the publication biases inherent to that research environment. Mechanistic data from the peptides is more robust than outcome data.

Side Effects

Selank: Exceptionally well tolerated. No withdrawal reported. No significant interaction with standard anxiolytics in the literature. Some users report mild fatigue at higher doses. Not recommended to combine with high-dose benzodiazepines due to GABA pathway overlap.

Semax: Generally well tolerated. The main concern is mild overstimulation at higher doses (>600 mcg). Some users report irritability with chronic daily use and recommend cycling — 3–4 weeks on, 1–2 weeks off. No neurotoxicity detected in animal studies.

Who Should Choose Which

Choose Selank primarily if you:

• Struggle with generalized anxiety, social anxiety, or phobias
• Want cognitive performance without stimulant-like arousal
• Have immune dysregulation alongside cognitive/mood concerns
• Are sensitive to stimulants or prone to anxiety from nootropics

Choose Semax primarily if you:

• Want maximum cognitive enhancement, focus, and memory support
• Are recovering from neurological insult (stroke, TBI, post-COVID cognitive fog)
• Want to increase BDNF for neuroplasticity and depression resistance
• Can tolerate mild stimulation

Stack both if you:

• Want calm, sustained cognitive performance
• Have both anxiety and cognitive concerns simultaneously
• Are optimizing for complex work, high-stakes performance, or learning-intensive periods

Frequently Asked Questions

Q: Can you mix Selank and Semax in the same nasal solution? Many users do combine them in the same intranasal dose. There is no known incompatibility. This is a common practice in the nootropic community and appears safe based on extensive anecdotal use.

Q: How does Selank compare to benzodiazepines for anxiety? Selank modulates GABA-A receptors but through a different binding site than benzodiazepines, producing anxiolysis without the sedation, dependence, or cognitive impairment. It is far less powerful acutely than diazepam but much safer for long-term use.

Q: Does Semax cause dopamine depletion with chronic use? Some users report tolerance with daily use for extended periods. Cycling (3–4 weeks on, 1 week off) appears to maintain effectiveness and prevent receptor downregulation.

Q: Is intranasal the only effective route? Subcutaneous injection is also used and produces reliable absorption, but the intranasal route is preferred for peptides with CNS targets because it allows direct olfactory/nasal epithelium delivery that bypasses the blood-brain barrier to some extent.

Q: How does Semax compare to other BDNF-raising approaches like exercise and lion's mane? Semax produces a more acute and pronounced BDNF spike than most supplements. Exercise is arguably the most evidence-based BDNF intervention long-term. Lion's mane mushroom raises NGF and has accumulating human cognitive data. These approaches are complementary rather than competing.